Oura Ring Gen 4 sensor data, not clinical measurementsN=1 case study, not validated for clinical decisionsHEV diagnosed Mar 18; Day 205 post-ruxolitinibMore
Consumer wearable data can support exploratory review only. The HEV diagnosis, temporally confounded with treatment start, remains a material confounder.

Advanced HRV Analysis

RMSSD epochs: 22,740 | HR measurements: 182,298
DFA alpha-1 (RMSSD-Epoch Proxy)
Abnormal
1.1092
Applied to RMSSD epochs (not RR intervals) - ref ~1.0 (not directly comparable) | 95% KI: (1.064, 1.109)
Sample Entropy
Low
1.5534
Healthy: 1.5-2.5 | normal
Toichi CVI (vagal)
Low
2.1147
Healthy: 3.255
Allostatic Load
2/7
mild
Baevsky SI
2.93
Normal: <150 | normal
Cosinor Amplitude
Low
5.22bpm
Healthy: 15-25 bpm | Acrophase: 09:29
RQA Determinism
Low
0.4451
Healthy: >0.6 | moderately_reduced
Nightly HR CV
Elevated
13.45%
Mean: 73.5 bpm | high_variability
REPORT SECTION

1. Proxy Frequency Spectrum (Lomb-Scargle)

Note: Analysis based on 5-minute RMSSD epochs (not beat-to-beat RR intervals). Nyquist frequency is limited to ~0.00167 Hz, so the table below uses proxy bands across the accessible spectrum only. These labels are heuristic and do not support standard LF/HF physiology claims.
BandPowerProportionInterpretation
Lower proxy band0.06.3%Lowest third of accessible RMSSD-epoch spectrum
Mid proxy band0.075.6%Middle third of accessible RMSSD-epoch spectrum
Upper proxy band0.018.2%Upper third of accessible RMSSD-epoch spectrum
Upper/lower proxy ratio4.156Heuristic spectral balance only; not a standard sympathovagal index
REPORT SECTION

2. Multiscale Entropy (MSE)

Pattern: High entropy preserved - possible inflammatory pattern

Low-scale mean: 0.6658 | High-scale mean: 0.7802

Costa et al. 2005: Healthy systems show high entropy across all scales. Neuropathic disease shows decline at high scales.

REPORT SECTION

3. Recurrence Quantification Analysis (RQA)

MetricValueInterpretation
Recurrence Rate (RR)0.0032Proportion of recurrent states
Determinism (DET)0.4451Reduced predictability
Laminarity (LAM)0.2021Degree of intermittency
Diagonal Entropy1.1499Complexity of diagonal lines
Moderately reduced determinism
REPORT SECTION

4. RMSSD-Epoch DFA (Proxy)

Note: DFA is originally designed for beat-to-beat RR-interval time series. Applied here to 5-minute RMSSD epochs as a proxy. Reference values from RR-interval studies; RMSSD-epoch DFA values are not directly comparable.
ParameterValue95% CIReference (RR-interval literature)
alpha-1 (short-term)1.1092(1.064, 1.109)~1.0 (RR-interval ref; proxy may differ)
alpha-2 (long-term)0.9957(0.876, 0.996)~1.0 (RR-interval ref; proxy may differ)
alpha (full)0.924-~1.0 (RR-interval ref)
Within normal range (RMSSD-epoke-proxy; RR-intervall-terskel ~1.0 - ikke validert for denne metoden)
REPORT SECTION

5. Approximate Entropy (ApEn) and Sample Entropy (SampEn)

MetricValueParametersHealthy Reference
ApEn1.5808m=2, r=3.0883~1.0-1.5
SampEn1.5534m=2, r=3.0883~1.5-2.5
Normal complexity
REPORT SECTION

6. Hjorth Parameters

ParameterValueDescription
Activity238.4447 ms2Signal variance (power)
Mobility0.5697Mean frequency (low = monotonous signal)
Complexity2.7723Rate of frequency change
REPORT SECTION

7. Baevsky Stress Index (SI)

ComponentValue
AMo (mode amplitude)5.57%
Mo (mode)8.25 ms
MxDMn (range)115.0 ms
SI (scaled)2.93
Normal stress level
Reference (Baevsky 2002): Normal <150, Moderate 150-500, High >500, Pathological >1000
REPORT SECTION

8. Toichi CVI/CSI (Vagal/Sympathetic Index)

ParameterPatientHealthy Reference% of Normal
SD1 (vagal)6.22 ms30 ms20.7%
SD2 (sympathetic)20.934 ms60 ms34.9%
CVI2.11473.255-
CSI3.36542.0-
CVI=2.11 (healthy ref: 3.26) - severely reduced vagal tone. CSI=3.37 (healthy ref: 2.0) - sympathetic dominance.
REPORT SECTION

9. Cosinor Circadian Analysis (Heart Rate)

ParameterValueReference
MESOR85.8 bpm60-80 bpm (healthy)
Amplitude5.22 bpm15-25 bpm
Acrophase09:2914:00-17:00
R20.0391>0.3 for significant rhythm
Flattened circadian rhythm
REPORT SECTION

10. HR Complexity (Permutation and Spectral Entropy)

MetricValueHealthy Reference
Permutation Entropy (PE)0.9752>0.85
Spectral Entropy (SE)0.6903>0.80
Normal ordinal pattern complexity
REPORT SECTION

11. Night-to-Night HR Variability

ParameterValue
Number of Nights297
Mean Nocturnal HR73.5 bpm
SD Nocturnal HR9.88 bpm
CV13.45%
Min-Max56.5 - 113.9 bpm
Trendstable trend (-0.08 bpm/night)
REPORT SECTION

12. Wearable Allostatic Load Score

2 / 7 MILD

BiomarkerValueThresholdStatus
Hr Avg Sleep 73.5 bpm > 80 bpm OK
Hrv Rmssd 21.8 ms > 15 ms OK
Sleep Efficiency 73.2 % < 85 % EXCEEDED
Temp Deviation 0.244 °C > 0.5 °C OK
Spo2 95.62 % < 95 % OK
Deep Sleep Pct 17.8 % < 10 % OK
Rem Sleep Pct 13.4 % < 15 % EXCEEDED
Mild allostatic load (2/7)
REPORT SECTION

Clinical Summary

Key Findings:
Advanced analysis of 22,740 RMSSD epochs and 182,298 heart rate measurements confirms severe autonomic dysfunction in this post-hsct patient.

Key Metrics:
  • DFA alpha-1 (RMSSD-Epoch Proxy) = 1.1092 (RR-interval ref ~1.0; proxy may differ): Within normal range (RMSSD-epoke-proxy; RR-intervall-terskel ~1.0 - ikke validert for denne metoden)
  • SampEn = 1.5534 (RR-interval ref 1.5-2.5; RMSSD-epoch may differ): Normal complexity
  • Toichi CVI = 2.1147 (reference 3.255): Severely reduced vagal tone
  • Cosinor amplitude = 5.22 bpm (reference 15-25): Flattened circadian rhythm
  • Allostatic load score = 2/7: mild
  • RQA determinism = 0.4451: Moderately reduced determinism

Clinical Interpretation:
Combined analyses show a pattern consistent with severe autonomic neuropathy with both parasympathetic failure (low CVI, low SampEn, low SD1) and chronodisruption (low cosinor amplitude). MSE pattern (inflammatory) and DFA findings support loss of fractal dynamics. The high allostatic load (2/7) indicates systemic physiological stress exceeding adaptive capacity.

Analysis based on Oura Ring Gen 4 data (Jan-Mar 2026). RMSSD epochs are 5-minute intervals during sleep. DFA and SampEn are computed from RMSSD epochs (proxy) - not beat-to-beat RR intervals. Reference values from RR-interval studies are not directly comparable. Frequency domain values are approximations based on Lomb-Scargle periodogram, not beat-to-beat analysis, and should be interpreted as relative indicators. Population norms for RMSSD are from controlled clinical 5-minute recordings; consumer wearable nocturnal values may differ.